Literature DB >> 12504623

Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma.

Luis M Puig-Tintoré1, Jaume Ordi, Sergi Vidal-Sicart, José A Lejárcegui, Aureli Torné, Jaume Pahisa, Xavier Iglesias.   

Abstract

OBJECTIVE: The aim was to determine the feasibility of surgical identification and pathological ultrastaging of sentinel nodes (SNs) in vulvar carcinoma and to evaluate whether SN negativity rules out the possibility of metastasis in other nodes and can therefore avoid conventional lymphadenectomy.
MATERIAL AND METHODS: In 26 patients with vulvar squamous cell carcinoma the SNs were detected using both peritumoral injection of (99m)Tc and blue dye (isosulfan or methylene) before the surgical procedure. Dissection of the SNs was followed by standard lymphadenectomy and vulvar exeresis. For pathological ultrastaging at least eight histological sections of every node separated 400 microm were evaluated using hematoxylin & eosin and immunostaining against cytokeratin.
RESULTS: We identified the SNs in 25/26 patients (96%). In 19 patients (76%) the SN was unilateral and in 6 (24%) it was bilateral. A total of 46 SNs were isolated. Metastatic carcinoma was identified in 9 SNs from 8 patients (30.8%). Thirty-eight percent (3 of 8) patients with metastatic SNs presented micrometastasis detected only in ultrastaging. Seven (3.3%) of 239 nonsentinel nodes (non-SNs) showed metastasis. No metastatic implant was detected in non-SNs when SNs were negative in patients without clinical suspicious adenopathy (100% negative predictive value).
CONCLUSION: Inguinofemoral lymph nodes can be confidently avoided when sentinel node metastases are excluded by histological ultrastaging. This may reduce the surgical morbidity of conventional inguinofemoral lymphadenectomy, without worsening vulvar cancer prognosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12504623     DOI: 10.1006/gyno.2002.6857

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

Review 1.  Lymphatic mapping and sentinel node detection in gynecologic malignancies of the lower genital tract.

Authors:  Michael Frumovitz; Pedro T Ramirez; Charles Levenback
Journal:  Curr Oncol Rep       Date:  2005-11       Impact factor: 5.075

Review 2.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

Review 3.  Sentinel lymph nodes in gynaecological malignancies: frontline between TNM and clinical staging systems?

Authors:  Katalin Zámbó; Miklós Koppán; Adrián Paál; Erzsébet Schmidt; Hans-Rudolf Tinneberg; József Bódis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-11       Impact factor: 9.236

Review 4.  Lymphoscintigraphy and sentinel lymph node biopsy in vulvar carcinoma: update from a European expert panel.

Authors:  Angela Collarino; Valentina Fuoco; Giorgia Garganese; Lenka M Pereira Arias-Bouda; Germano Perotti; Gianpiero Manca; Sergi Vidal-Sicart; Francesco Giammarile; Lioe-Fee de Geus-Oei; Giovanni Scambia; Alessandro Giordano; Renato A Valdés-Olmos; Marco Maccauro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01-02       Impact factor: 9.236

5.  Sentinel lymph node mapping in early stage of endometrial and cervical cancers.

Authors:  Tajossadat Allameh; Vahidehsadat Hashemi; Fereshteh Mohammadizadeh; Fariba Behnamfar
Journal:  J Res Med Sci       Date:  2015-02       Impact factor: 1.852

Review 6.  The sentinel node in gynaecological malignancies.

Authors:  J Balega; P O Van Trappen
Journal:  Cancer Imaging       Date:  2006-02-28       Impact factor: 3.909

Review 7.  Lymphatic mapping and sentinel node biopsy in gynecological cancers: a critical review of the literature.

Authors:  Ali Ayhan; Husnu Celik; Polat Dursun
Journal:  World J Surg Oncol       Date:  2008-05-20       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.